Pharmaceutical Technology - September 2021

Pharmaceutical_Technology_PTE_Regulatory_Sourcebook_September_2021

Issue link: https://www.e-digitaleditions.com/i/1411460

Contents of this Issue

Navigation

Page 2 of 48

REGULATORY OVERSIGHT 4 Understanding Combination Product Regulations Jennifer Markarian 8 Considering Titanium Dioxide Regulatory Changes Jennifer Markarian DRUG SAFETY 10 The Real Danger of Substandard and Counterfeit COVID-19 Vaccines Meg Rivers 16 Changing the Course of Drug Shortages Meg Rivers BEST PRACTICES: PART 1 23 Sampling and Testing Nomenclature for Pharmaceutical Analysis: A Review of Current Practices Chris Burgess BEST PRACTICES: PART 2 34 Sampling and Testing Nomenclature for Pharmaceutical Analysis: A Simplified Approach Chris Burgess INDUSTRY PERSPECTIVES 42 Industry Organizations Assist Pharma During the Pandemic and Beyond The Editors of Pharmaceutical Technology 46 Mapping Out Pharma's Future Felicity Thomas 48 Ad Index On the cover: motortion - Stock.adobe.com Art Direction: Maria Reyes Regulatory Sourcebook September 2021

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - September 2021 - Pharmaceutical_Technology_PTE_Regulatory_Sourcebook_September_2021